Elutia (ELUT) Income towards Parent Company (2019 - 2026)
Elutia's (ELUT) quarterly Income towards Parent Company came in at -$7.6 million in Q2 2026, up 20.44% year-over-year from -$6.3 million in Q2 2025, and down 2.37% quarter-over-quarter from -$7.5 million in Q1 2026.
Analysis
Elutia (ELUT) Income towards Parent Company (2019 - 2026) Analysis & Trends
Elutia has disclosed Income towards Parent Company across 8 years of filings, most recently posting -$7.6 million for Q2 2026.
- In Q2 2026, Income towards Parent Company rose 20.44% year-over-year to -$7.6 million; the TTM figure through Jun 2026 stood at $55.1 million (up 358.51% YoY), while the FY2025 annual figure was $56.7 million, up 205.06% from the prior year.
- Income towards Parent Company came in at -$7.6 million for Q2 2026 at Elutia, down from -$7.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $74.1 million in Q4 2025 to a low of -$28.2 million in Q2 2024.
- Average Income towards Parent Company over 5 years is -$4.6 million, with a median of -$8.6 million recorded in 2022.
- The largest YoY upside for Income towards Parent Company was 917.7% in 2025 against a maximum downside of 400.78% in 2025.
- Over 5 years, Income towards Parent Company stood at -$5.4 million in 2022, then sank by 71.21% to -$9.3 million in 2023, then rose by 2.72% to -$9.1 million in 2024, then soared by 917.7% to $74.1 million in 2025, then tumbled by 110.32% to -$7.6 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$7.6 million in Q2 2026, -$7.5 million in Q1 2026, and $74.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn |
| 10 | Elutia | 37.26 Mn | 17.36 Mn | 1.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.65 Mn |
| Mar 31, 2026 | -7.47 Mn |
| Dec 31, 2025 | 74.09 Mn |
| Sep 30, 2025 | -3.87 Mn |
| Jun 30, 2025 | -9.61 Mn |
| Mar 31, 2025 | -3.93 Mn |
| Dec 31, 2024 | -9.06 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | -28.18 Mn |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | -9.31 Mn |
| Sep 30, 2023 | -9.75 Mn |
| Jun 30, 2023 | -10.62 Mn |
| Mar 31, 2023 | -7.97 Mn |
| Dec 31, 2022 | -5.44 Mn |
| Sep 30, 2022 | -9.91 Mn |
| Jun 30, 2022 | -9.40 Mn |
| Mar 31, 2022 | -8.15 Mn |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -8.32 Mn |